An in vivo study illustrated that stERAP increases the suppression of E2-induced tumor proliferation in mice via prolonged inhibition of BIG3-PHB2 interaction because of a higher PHB2-binding affinity compared with that of unstapled ERAP [37]. The gene discussed is PHB2; the disease is neoplasm.